Twitter
Email
RSS2009 Dividend Income Summary
2009 was a rough year for dividend income. For the past couple years I have been tracking a 30-50% growth rate in dividend income, but 2009 was the first year our dividend income actually shrank despite a net increase in stock holdings for the year. Its largerly explained by the dividend cuts of a number of blue-chip companies. For us the announcements of Pfizer, Wachovia/Well Fargo, and GE dividend cuts in 2009 all had significant impacts to our dividend income.
I pay close attention to our annual dividend income because its one piece of the passive income we are going to need once we hit our financial goals. As part of our passive income strategy we will need an annual cash flow to sustain ourselves once we reduce our earned income and before we can raid our retirement accounts.
Heres a look at our dividend income for 2009:
| Annual Dividends | |||
| Investment | 2007 | 2008 | 2009 |
| Pepco | $ 21.31 | $ 22.67 | $ 22.68 |
| AT&T | $ 18.48 | $ 20.80 | $ 21.32 |
| Bank of America | $ 1.00 | ||
| BP | $ 11.02 | ||
| CMS | $ 12.02 | $ 21.99 | $ 31.64 |
| Connoco | $ 28.49 | $ 44.78 | $ 106.56 |
| Chevron | $ 29.71 | $ 34.16 | $ 37.17 |
| Duke Energy | $ 92.15 | $ 100.98 | $ 111.83 |
| Edison | $ 14.48 | $ 15.57 | $ 16.35 |
| ExxonMobil | $ 70.07 | $ 80.66 | $ 88.24 |
| GE | $ 99.58 | $ 114.97 | $ 102.07 |
| Healthcare SPDR | $ - | $ - | $ 173.76 |
| IBM | $ 459.98 | $ 555.74 | $ 520.33 |
| Lowes | $ 11.37 | $ 14.59 | $ 15.72 |
| Medtronic | $ 39.97 | $ 53.74 | $ 68.70 |
| Merck | $ 206.25 | $ 212.83 | $ 222.68 |
| P&G | $ 40.33 | $ 46.94 | $ 53.52 |
| Pfizer | $ 803.70 | $ 972.66 | $ 255.60 |
| Rohn & Haas | $ 27.75 | ||
| Spectra | $ 29.95 | $ 45.07 | $ 49.54 |
| Anheuser Busch | $ 128.49 | $ 147.58 | $ - |
| Microsoft | $ 0.66 | $ 0.75 | $ 0.86 |
| Johnson & Johnson | $ 14.18 | $ 16.13 | $ 17.88 |
| Marsh&Mclennan | $ 10.76 | $ 46.14 | $ 35.60 |
| Union Bancshares | $ 6.00 | ||
| Wachovia | $ 23.95 | $ 360.57 | $ - |
| Wells Fargo | $ 40.82 | ||
| VXF | $ 69.99 | $ 66.84 | $ 55.31 |
| VWO | $ 87.34 | $ 108.32 | $ 52.62 |
| VTI | $ 0.76 | $ 96.93 | $ 337.00 |
| KBE ETF | $ - | $ 92.58 | $ 208.17 |
| Total | $2,313.97 | $3,293.99 | $2,691.74 |
For 2009 we saw a drop of about 18% in our net dividend income over 2008. While its a set back, we continued making investments with higher dividend yields in 2009 which should pay off in the long run.
You can also see our 2005 passive income, 2006 passive income, 2007 passive income, and 2008 passive income.
Similar Entries
Investment Performance June 2010 (-5.64%) (Jul 23, 2010) This is an ongoing monthly update on how our equity investments are performing. Please see this background on the investment tool I developed and how I am using it to track our performance against a benchmark to measure our progress...
Investment Performance May 2010 (-8.13%) (Jun 14, 2010) This is an ongoing monthly update on how our equity investments are performing. Please see this background on the investment tool I developed and how I am using it to track our performance against a benchmark to measure our progress...
Investment Performance April 2010 (+2.54%) (May 09, 2010) This is an ongoing monthly update on how our equity investments are performing. Please see this background on the investment tool I developed and how I am using it to track our performance against a benchmark to measure our progress...
Comments (1)
A lot of investors sw decreases in their dividend incomes in 2009 as a result of dividned cuts in the financial sector. I do find it interesting however that you had almost 30% of your income coming up in Pfizer. I think you should have a diversified income stream, not a concentrated one. Right now you have 20% of your income coming from IBM. In an ideal situation I would not depend on a single stock for more than 5% of the dividend income.
Posted by Dividend Growth Investor | March 3, 2010 5:35 PM